Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes

被引:23
|
作者
Lenze, Nicholas R. [1 ]
Farquhar, Douglas [1 ]
Sheth, Siddharth [2 ]
Zevallos, Jose P. [3 ]
Blumberg, Jeffrey [1 ]
Lumley, Catherine [1 ]
Patel, Samip [1 ]
Hackman, Trevor [1 ]
Weissler, Mark C. [1 ]
Yarbrough, Wendell G. [1 ,5 ]
Zanation, Adam M. [1 ]
Olshan, Andrew F. [4 ]
机构
[1] Univ N Carolina, Sch Med, Dept Otolaryngol Head & Neck Surg, 170 Manning Dr,Campus Box 7070, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA
[3] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA
[4] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27515 USA
来源
LARYNGOSCOPE | 2021年 / 131卷 / 06期
关键词
Head and neck neoplasms; race; disparities; access to care; socioeconomic status; survival; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; AFRICAN-AMERICAN; HEALTH LITERACY; UNITED-STATES; ORAL-HEALTH; SURVIVAL; IMPACT; RACE;
D O I
10.1002/lary.29252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis To determine drivers of the racial disparity in stage at diagnosis and overall survival (OS) between black and white patients with HPV-negative head and neck squamous cell carcinoma (HNSCC). Study Design Retrospective cohort study. Methods Data were examined from of a population-based HNSCC study in North Carolina. Multivariable logistic regression and Cox proportional hazards models were used to assess racial disparities in stage at diagnosis and OS with sequential adjustment sets. Results A total of 340 black patients and 864 white patients diagnosed with HPV-negative HNSCC were included. In the unadjusted model, black patients had increased odds of advanced T stage at diagnosis (OR 2.0; 95% CI [1.5-2.5]) and worse OS (HR 1.3, 95% CI 1.1-1.6) compared to white patients. After adjusting for age, sex, tumor site, tobacco use, and alcohol use, the racial disparity persisted for advanced T-stage at diagnosis (OR 1.7; 95% CI [1.3-2.3]) and showed a non-significant trend for worse OS (HR 1.1, 95% CI 0.9-1.3). After adding SES to the adjustment set, the association between race and stage at diagnosis was lost (OR: 1.0; 95% CI [0.8-1.5]). Further, black patients had slightly favorable OS compared to white patients (HR 0.8, 95% CI [0.6-1.0]; P = .024). Conclusions SES has an important contribution to the racial disparity in stage at diagnosis and OS for HPV-negative HNSCC. Low SES can serve as a target for interventions aimed at mitigating the racial disparities in head and neck cancer. Level of Evidence 4 Laryngoscope, 2020
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 50 条
  • [11] Racial Disparities in Perioperative Outcomes for Patients With Head and Neck Cancer
    Fereydooni, Soraya
    Valdez, Caroline
    Williams, Lauren C.
    Verma, Avanti
    Judson, Benjamin
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024,
  • [12] Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
    Wegge, Marilyn
    Dok, Ruveyda
    Nuyts, Sandra
    CANCERS, 2021, 13 (23)
  • [13] Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients
    Wan, Yunxia
    Vagenas, Dimitrios
    Salazar, Carolina
    Kenny, Liz
    Perry, Chris
    Calvopina, Diego
    Punyadeera, Chamindie
    ONCOTARGET, 2017, 8 (59) : 99990 - 100001
  • [14] Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
    Benavente, Sergi
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 291 - 313
  • [15] Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
    Burtness, Barbara
    Bauman, Julie E.
    Galloway, Thomas
    LANCET ONCOLOGY, 2013, 14 (08): : E302 - E309
  • [16] Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer
    Zenga, Joseph
    Awan, Musaddiq
    Kondelaji, Mir Hadi Razeghi
    Hansen, Christopher
    Shafiee, Shayan
    Frei, Anne
    Foeckler, Jamie
    Kuehn, Rachel
    Bruening, Jennifer
    Massey, Becky
    Wong, Stuart
    Joshi, Amit
    Himburg, Heather A.
    ORAL ONCOLOGY, 2023, 144
  • [17] Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients
    Farquhar, Douglas R.
    Masood, Maheer M.
    Lenze, Nicholas R.
    Tasoulas, Jason
    Sheth, Siddharth
    Lumley, Catherine
    Blumberg, Jeffrey
    Yarbrough, Wendell G.
    Zevallos, Jose
    Weissler, Mark C.
    Zanation, Adam M.
    Hackman, Trevor G.
    Olshan, Andrew F.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (12): : 2981 - 2989
  • [18] Deciphering the Tumor-Immune-Microbe Interactions in HPV-Negative Head and Neck Cancer
    Hu, Min
    Coleman, Samuel
    Fadlullah, Muhammad Zaki Hidayatullah
    Spakowicz, Daniel
    Chung, Christine H.
    Tan, Aik Choon
    GENES, 2023, 14 (08)
  • [19] EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
    Beck, Tim N.
    Georgopoulos, Rachel
    Shagisultanova, Elena I.
    Sarcu, David
    Handorf, Elizabeth A.
    Dubyk, Cara
    Lango, Miriam N.
    Ridge, John A.
    Astsaturov, Igor
    Serebriiskii, Ilya G.
    Burtness, Barbara A.
    Mehra, Ranee
    Golemis, Erica A.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (10) : 2486 - 2497
  • [20] Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals
    Madathil, Sreenath
    Rousseau, Marie-Claude
    Joseph, Lawrence
    Coutlee, Francois
    Schlecht, Nicolas F.
    Franco, Eduardo
    Nicolau, Belinda
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 56 - 64